We propose that the magnified combined effect of SNPs in GAS5, miR-146a, IRAK-1, and miR-155a genes may influence the risk of MS and its phenotypes through epistatic interactions and could aid in the risk stratification of MS patients. The gene discussed is GAS5; the disease is myeloid sarcoma.